- Prof. Annalisa Berzigotti, Switzerland
- Prof. Jean-François Dufour, Switzerland
- Prof. Andrea de Gottardi, Switzerland
This is a school following the new model of ‘flip-class’ with an active participation of the fellows who have to answer a complex question related to a real case. They are working in a group of 5 under the supervision of a faculty and they have to present their answers the next day in front of an extended faculty with specialists from other disciplines.
Vascular liver diseases are a diverse group of diseases which are frequent in clinical practice and complex, multidisciplinary in their management. With the large availability of ultrasonography, these diseases are more and more recognized and hepatologists should know how to handle them. They should also be aware of the limitations of the current knowledge and the area which could be better researched.
This school will provide an in-depth analysis of 6 real cases of patients with vascular liver diseases.
The fellows will be updated on the current evidence-based practices and the literature leading to recommendations. The fellows will be engaged in discussions with experts from different specialities involved in the management of these patients. It is expected that the attendees will gain awareness and familiarity in the management of vascular liver diseases.
About EASL Schools
The schools contribute to the training of new generations of hepatologists and are a major element of our association. Aimed at young fellows enrolled in hepatology-oriented departments or more experienced clinicians who want to be exposed to the newest trends in hepatology.
For selected applicants, EASL will cover transportation costs to attend the school and accommodation during the event (details will be provided individually once the selection process has been done).
Application is open to young fellows under the age of 35 and/or still in training.
Approximately 30 places are available for each school and priority is given to registered EASL members during the selection process.
Supported by AbbVie, Bristol-Myers Squibb and MSD who provided funding.
AbbVie, Bristol-Myers Squibb and MSD have had no input into the content of the materials and presentations used at this event.
CME Credit Information
The DIAGNOSIS AND MANAGEMENT OF VASCULAR LIVER DISEASES, Bern, Switzerland, 23/11/2018-24/11/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Each participant can only receive the number of credits he/she is entitled to according to his/her actual participation at the event once he/she has completed the feedback form. Cf. criteria 9 and 23 of UEMS 2016.20.
In order to help you issue individual certificates to each participants, please find below the breakdown of ECMEC®s per day:
23.11.2018 – 7,00
24.11.2018 – 5,00
The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8 ECMEC®s per day. Cf. Chapter X of UEMS 2016.20.